对急性呼吸衰竭患者的间接热量计的实施:关于技术和程序的邀请评论
Ashlee Roffe1, Michelle L Schneider2, Michelle Brown3
1Nutrition and Community Health, Endeavor Health Swedish Hospital, Chicago, Illinois, USA.
概括
间接热量计 (IC) 可以准确地测量呼吸衰竭患者的能量需求. 本综述详细介绍了IC如何改善机械通风患者的临床决策和营养护理.
科学领域:
- 关键护理医学 关键护理医学
- 营养支持营养支持
- 呼吸系统医学 呼吸系统医学
背景情况:
- 呼吸系统衰竭对营养摄入造成了重大挑战,并增加了营养不良的风险.
- 目前用于呼吸衰竭的能量需求的预测方程往往不准确和复杂.
- 间接热量计 (IC) 提供了一个精确的床边方法来评估能源消耗.
研究的目的:
- 审查间接热量计在指导临床决策和营养治疗中的应用.
- 为了说明IC在第三级和社区医院环境中的使用.
- 概述在患者护理中成功实施IC的战略.
主要方法:
- 关于呼吸衰竭中间接热量计的当前文献的综述.
- 案例示例展示了IC在各种医院环境中的使用情况.
- 讨论IC采用和整合到临床工作流程中的实际策略.
主要成果:
- 间接热量计提供准确的,个性化的能源消耗测量.
- IC数据可以直接影响营养支持决策,优化热量输送.
- 成功的采用需要多学科的合作和员工教育.
结论:
- 间接热量计是优化机械通风患者呼吸衰竭营养支持的宝贵工具.
- 实施IC可以通过确保精确的能源供应来改善患者的治疗结果.
- 标准化IC的使用可以提高关键性呼吸系统疾病患者的护理质量.
相关概念视频
Assessment of Respiration
2.4K
The respiratory system's basic structures and primary functions lay the foundation for nurses' comprehensive respiratory assessments. This assessment includes subjective and objective data to gauge the patient's respiratory health.
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like...
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like...
2.4K
Acute Respiratory Failure-I
1.6K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.6K
Acute Respiratory Failure-II
1.6K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.6K
Acute Respiratory Failure-III
1.2K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.2K
Acute Respiratory Failure-IV
749
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
749
Acute Respiratory Failure-V
678
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
678


